Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Cuiping ZHANG, Xiaoyan CHEN, Tianchang WEI, Juan SONG, Xinjun TANG, Jing BI, Cuicui CHEN, Jian ZHOU, Xiao SU & Yuanlin SONG. (2023) Xuebijing alleviates LPS-induced acute lung injury by downregulating pro-inflammatory cytokine production and inhibiting gasdermin-E-mediated pyroptosis of alveolar epithelial cells. Chinese Journal of Natural Medicines 21:8, pages 576-588.
Crossref
Crossref
Jie Lv, Xiaoxia Guo, Huiying Zhao, Gang Zhou & Youzhong An. (2022) Xuebijing Administration Alleviates Pulmonary Endothelial Inflammation and Coagulation Dysregulation in the Early Phase of Sepsis in Rats. Journal of Clinical Medicine 11:22, pages 6696.
Crossref
Crossref
Mengting Li, Hongfei Zhu, Yafei Liu, Yao Lu, Minyao Sun, Yuqing Zhang, Jiaheng Shi, Nannan Shi, Ling Li, Kehu Yang, Xin Sun, Jie Liu, Long Ge & Luqi Huang. (2022) Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies. Frontiers in Pharmacology 13.
Crossref
Crossref
Zhe-Hao Jin, Xiao-Qing Zhao, Hai-Bin Sun, Jing-Li Zhu & Wei Gao. (2022) Effect of Xuebijing injection on myocardium during cardiopulmonary bypass: A prospective, randomized, double blind trial. World Journal of Clinical Cases 10:13, pages 4110-4118.
Crossref
Crossref
Ping Geng, Bing-yu Ling, Hong-liang Zhang, Jia-li Xiong, Ying Wang, Fen Yu, Ding-yu Tan, Ji-yang Xu & Hui-hui Wang. (2021) Xuebijing Injection Ameliorates H2S-Induced Acute Respiratory Distress Syndrome by Promoting Claudin-5 Expression. Chinese Journal of Integrative Medicine 28:2, pages 116-123.
Crossref
Crossref
Yu Wang, Cheng Lu, Hao Li, Wensheng Qi, Lianguo Ruan, Yongjun Bian, Huaxin Shi, Hui Song, Shengjin Tu, Yan Zhang, Tao Bai, Rong Cao, Ke Hong, Huadong Li, Li Liu, Sixia Lu, Nianhe Rong, Yue Liu, Jiliang Fang, Jiaheng Shi, Wei Yang, Bin Zhao, Yang Yang, Yufeng Zhao, Shaoyuan Li, Tiebing Fan, Peijing Rong & Luqi Huang. (2021) Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China. Journal of Ethnopharmacology 277, pages 113888.
Crossref
Crossref
Kangqiao Xu, Yaqin Wei, Sergio Giunta, Min Zhou & Shijin Xia. (2021) Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?. Experimental Gerontology 151, pages 111423.
Crossref
Crossref
Jiancheng Zhang, Bing Xie & Kenji Hashimoto. (2020) Current status of potential therapeutic candidates for the COVID-19 crisis. Brain, Behavior, and Immunity 87, pages 59-73.
Crossref
Crossref
Jiwei Li, Li Wei, Zhijun Han, Zhong Chen & Quan Zhang. (2020) Long non-coding RNA X-inactive specific transcript silencing ameliorates primary graft dysfunction following lung transplantation through microRNA-21-dependent mechanism. EBioMedicine 52, pages 102600.
Crossref
Crossref
Wei Gao, Na Li & Xiao-guang Cui. (2018) Efficacy of Xuebijing Injection (血必净注射液) on Cardiopulmonary Bypass-Associated Pulmonary Injury: A Prospective, Single-center, Randomized, Double Blinded Trial. Chinese Journal of Integrative Medicine 24:11, pages 815-821.
Crossref
Crossref
Fei He, Jun Wang, Yao Liu, Xiaojing Wang, Nan Cai, Chao Wu & Qingling Gao. (2018) Xuebijing injection induces anti-inflammatory-like effects and downregulates the expression of TLR4 and NF-κB in lung injury caused by dichlorvos poisoning. Biomedicine & Pharmacotherapy 106, pages 1404-1411.
Crossref
Crossref
Tanye Xu, Lin Zhou, Yingying Shi, Liwei Liu, Lihua Zuo, Qingquan Jia, Shuzhang Du, Jian Kang, Xiaojian Zhang & Zhi Sun. (2018) Metabolomics approach in lung tissue of septic rats and the interventional effects of Xuebijing injection using UHPLC-Q-Orbitrap-HRMS. The Journal of Biochemistry.
Crossref
Crossref
F.-B. Tang, Y.-L. Dai, S. Hu, L.-Q. Ma, J.-Y. Li, H.-P. Zhang, W.-H. Zhang, Y.-G. Li, H.-B. Wang, H.-Y. Lin, Q. Hu & L. Li. (2017) Xuebijing injection treatment inhibits vasopermeability and reduces fluid requirements in a canine burn model. European Journal of Trauma and Emergency Surgery 43:6, pages 875-882.
Crossref
Crossref
Jia-jun Xu, Jian-tao Zhen, Li Tang & Qing-ming Lin. (2017) Intravenous injection of Xuebijing attenuates acute kidney injury in rats with paraquat intoxication. World Journal of Emergency Medicine 8:1, pages 61.
Crossref
Crossref
Sarah Mousavi, Alireza Ghannadi & Mohsen Meidani. (2016) New horizon in the treatment of sepsis: a systematic review of alternative medicine. Journal of Complementary and Integrative Medicine 13:4, pages 317-332.
Crossref
Crossref
Xiqiang Liu, Zhiqiu Hu, Bin Zhou, Xiang Li & Ran Tao. (2015) Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury. PLOS ONE 10:7, pages e0131436.
Crossref
Crossref
Ping Gong, Zhidan Lu, Jing Xing, Na Wang & Yu Zhang. (2015) Traditional Chinese Medicine Xuebijing Treatment Is Associated with Decreased Mortality Risk of Patients with Moderate Paraquat Poisoning. PLOS ONE 10:4, pages e0123504.
Crossref
Crossref
宏山 李. (2015) Xuebijing Regulate the Hypothalamic-Pituitary-Adrenal Axis and the Level of GRmRNA of Adrenal in Septic Rats. Advances in Clinical Medicine 05:02, pages 112-117.
Crossref
Crossref
Qiao Wang, Xin Wu, Xiaowen Tong, Zhiling Zhang, Bing Xu & Wugang Zhou. (2015) Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-9.
Crossref
Crossref
Yan-Cun Liu, Feng-Hua Yao, Yan-Fen Chai, Ning Dong, Zhi-Yong Sheng & Yong-Ming Yao. (2015) Xuebijing Injection Promotes M2 Polarization of Macrophages and Improves Survival Rate in Septic Mice. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-9.
Crossref
Crossref
MING-WEI LIU, YUN-HUI WANG, CHUAN-YUN QIAN & HUI LI. (2014) Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis. International Journal of Molecular Medicine 34:6, pages 1492-1504.
Crossref
Crossref
Xian-Di He, Yan Wang, Qiong Wu, Hua-Xue Wang, Zhen-Dong Chen, Rong-Sheng Zheng, Zi-Shu Wang, Jun-Bin Wang & Yan Yang. (2013)
Xuebijing Protects Rats from Sepsis Challenged with
Acinetobacter baumannii
by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion
. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-11.
Crossref
Crossref
Xiaofang Gao, Weizhen Chen, Zhixin Liang & Liangan Chen. (2011) Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit. International Immunopharmacology 11:10, pages 1584-1590.
Crossref
Crossref